These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 3052079)
1. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079 [TBL] [Abstract][Full Text] [Related]
2. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
4. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
5. Lack of metabolic effects of a triphasic formulation containing norethindrone in normal women studied prospectively. Toth EL; Ryan EA Contraception; 1988 Jun; 37(6):549-54. PubMed ID: 3293908 [TBL] [Abstract][Full Text] [Related]
6. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D; Smith S; Zacur H Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, secretion, and metabolism in users of oral contraceptives. Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790 [TBL] [Abstract][Full Text] [Related]
8. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months. Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC Contraception; 1988 Jul; 38(1):27-35. PubMed ID: 3139358 [TBL] [Abstract][Full Text] [Related]
9. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone. Spellacy WN; Ellingson AB; Tsibris JC J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750 [TBL] [Abstract][Full Text] [Related]
10. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use. Spellacy WN; Ellingson AB; Tsibris JC Fertil Steril; 1989 Jan; 51(1):71-4. PubMed ID: 2642814 [TBL] [Abstract][Full Text] [Related]
11. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate metabolism studies in women using Brevicon, a low-estrogen type of oral contraceptive, for one year. Spellacy WN; Buhi WC; Birk SA; Van Arnarn JB Am J Obstet Gynecol; 1982 Jan; 142(1):105-8. PubMed ID: 7034537 [TBL] [Abstract][Full Text] [Related]
13. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive. Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373 [TBL] [Abstract][Full Text] [Related]
14. A clinical comparison of two triphasic oral contraceptives with levonorgestrel or norethindrone: a prospective, randomized, single-blind study. Masson S; Franssen E; Hilditch JR; Powell MG Contraception; 1993 Jan; 47(1):43-54. PubMed ID: 8436001 [TBL] [Abstract][Full Text] [Related]
15. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Nayak RK Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new triphasic oral contraceptive in private practice. Ellsworth HS; Ayerst RI; Harris JW; Stone RA; Anderson AE; Jones TL; Curtis MK Contraception; 1986 Nov; 34(5):435-42. PubMed ID: 3102161 [TBL] [Abstract][Full Text] [Related]
17. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Spellacy WN Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318 [TBL] [Abstract][Full Text] [Related]
18. Contraception for women with diabetes: an update. Skouby SO; Mølsted-Pedersen L; Petersen KR Baillieres Clin Obstet Gynaecol; 1991 Jun; 5(2):493-503. PubMed ID: 1954724 [TBL] [Abstract][Full Text] [Related]
19. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
20. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol. Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]